Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GERON CORP | 180,000 | reported | 21 May 2025 | tx 21+1,239,300−140,000 |
| ARADIGM CORP | 150,000 | reported | 07 Mar 2006 | tx 2+400,000 |
| Spyre Therapeutics, Inc. | 43,000 | reported | 07 Jun 2022 | tx 5+160,300 |
| BIOMARIN PHARMACEUTICAL INC | 33,140 | reported | 23 May 2023 | tx 108+270,530−272,040 |
| SUTRO BIOPHARMA, INC. | 26,033 | reported | 26 Sept 2018 | tx 1+26,033 |
| KALOBIOS PHARMACEUTICALS INC | 20,000 | reported | 18 Jun 2014 | tx 2+40,000 |
| Coherus Oncology, Inc. | 20,000 | reported | 11 Jan 2021 | tx 14+242,497 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2025 | GRANT_AWARD | GERON CORP | 180,000 | 0.00 USD | deriv |
| 09 May 2025 | PURCHASE | GERON CORP | 13,300 | 1.18 USD | |
| 15 May 2024 | SALE | GERON CORP | 35,000 | 3.75 USD | |
| 15 May 2024 | EXERCISE | GERON CORP | 35,000 | 1.94 USD | |
| 15 May 2024 | EXERCISE | GERON CORP | 35,000 | 0.00 USD | deriv |
| 09 May 2024 | GRANT_AWARD | GERON CORP | 180,000 | 0.00 USD | deriv |
| 31 May 2023 | GRANT_AWARD | GERON CORP | 125,000 | 0.00 USD | deriv |
| 23 May 2023 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 4,190 | 0.00 USD | |
| 11 May 2023 | SALE | GERON CORP | 35,000 | 3.00 USD | |
| 11 May 2023 | EXERCISE | GERON CORP | 35,000 | 1.10 USD | |
| 11 May 2023 | EXERCISE | GERON CORP | 35,000 | 0.00 USD | deriv |
| 03 Apr 2023 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 8,500 | 67.81 USD | |
| 03 Apr 2023 | SALE | BIOMARIN PHARMACEUTICAL INC | 8,500 | 97.09 USD | |
| 03 Apr 2023 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 8,500 | 0.00 USD | deriv |
| 07 Jun 2022 | GRANT_AWARD | Spyre Therapeutics, Inc. | 43,000 | 0.00 USD | deriv |
| 24 May 2022 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 4,980 | 0.00 USD | |
| 10 May 2022 | GRANT_AWARD | GERON CORP | 125,000 | 0.00 USD | deriv |
| 14 Apr 2022 | SALE | BIOMARIN PHARMACEUTICAL INC | 4,250 | 83.66 USD | |
| 14 Apr 2022 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 4,250 | 37.46 USD | |
| 14 Apr 2022 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 4,250 | 0.00 USD | deriv |
| 14 Jan 2022 | SALE | BIOMARIN PHARMACEUTICAL INC | 4,250 | 87.61 USD | |
| 14 Jan 2022 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 4,250 | 37.46 USD | |
| 14 Jan 2022 | EXERCISE | BIOMARIN PHARMACEUTICAL INC | 4,250 | 0.00 USD | deriv |
| 08 Jun 2021 | GRANT_AWARD | Spyre Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 25 May 2021 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 5,120 | 0.00 USD |